PPARG and Nephropathy: In vitro studies have recently shown that through this peculiar function of PPAR-γ, telmisartan inhibits superoxide generation and monocyte chemoattractant protein-1 (MCP-1) gene expression in mesangial cells, thus exerting an anti-inflammatory activity against AGE-mediated kidney damage [27].